This is much better than $.50 purchase price, 125% warrant coverage, $.30 exercise price....yes its dilution, but much more favorable than previous rounds. Plus this could very likely go to pay the noteholder off that is getting $.50/shares monthly and selling as fast as they can and constantly putting pressure on the share price. I suspect this is to not get caught in the jam the noteholder put them in around New Year when they converted a several months worth all at once and CYDY didn't have the cash available.....likely when management was trying to take a few days off over the holidays.
As long as they don't request increase to AS, I'm not concerned of this impacting non-dilutive financing that is likely in the works.
(3)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.